CompletedNot Applicable

Comparing Between Air-Q Intubating Laryngeal Airway and Ambu® AuraGain™

Malaysia64 participantsStarted 2016-11

Plain-language summary

The aim of this randomized study is conducted is to evaluate the performance and safety of air-Q intubating laryngeal airway as primary airway device in various short surgical procedure in children compared to Ambu® AuraGain™ Laryngeal Mask. Current Supraglottic airway devices (SADs) available in are classic LMA (cLMA), proseal LMA (pLMA), supreme LMA (sLMA) and the newer is Ambu® AuraGain™laryngeal mask. As variety of newer SADs for children have emerged since their introduction in clinical practice, hope the outcomes of this study it help advancing our knowledge and acumen in selecting appropriate devices for paediatric population.

Who can participate

Age range1 Year – 6 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age between 1-6 years * Weight 10-30kg * American Society of Anesthesiologist (ASA) physical status class I and II * Any surgical procedures where supraglottic airway (SGA) management is appropriate * Duration of procedure within 2hours Exclusion Criteria: * Active respiratory infection * Anticipated and known difficult airway * Lung disease requiring high airway pressure

What they're measuring

measure fibreoptic (FO) grade of laryngeal view

Timeframe: 5 minutes after insertion of the device when good tidal volume is achieved

Trial details

NCT IDNCT03130413

SponsorUniversiti Sains Malaysia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-06-01

View on ClinicalTrials.gov More General Anaesthesia trials